Burden of illness associated with pneumococcal infections in Japan - a targeted literature review

References

• Matanock A, Lee G, Gierke R, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2019;68(46):1–14.
   PubMed Web of Science ®Google Scholar
• Committee for discussing Pneumococcal Vaccine Revaccination, National Institute of Infectious Diseases (NIID) Japan. [Guidelines on Pneumococcal Vaccine Revaccination]. 2009. [cited 2020 Dec 7]. Available from: http://www.kansensho.or.jp/uploads/files/guidelines/pneumococcus_vaccine.pdf
   Google Scholar
• World Health Organization. Pneumococcal disease [cited 2020 Mar 25]. Available from: https://www.who.int/ith/diseases/pneumococcal/en/
   Google Scholar
• Vital, Health and Social Statistics Office, Ministry of Health, Labour and Welfare. [Number of deaths, confirmed numbers, vital Statistics]. 2020. [updated 17 Sept 2020; cited 2020; cited 2020 Sept 2020; cited 2020 17 Dec 17 Sept 2020; cited 2020 17]. Available from: https://www.e-stat.go.jp/stat-search/files?page=1&layout=datalist&toukei=00450011&tstat=000001028897&cycle=7&year=20190&month=0&tclass1=000001053058&tclass2=000001053061&tclass3=000001053065&stat_infid=000031982756&result_back=1&result_page=1&tclass4val=0
   Google Scholar
• National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases, Centers for Disease Control and Prevention (CDC). About pneumococcal disease. [updated 21 Nov, 2019; cited 2019; cited 2020 Nov, 2019; cited 2020 25 Mar 21 Nov, 2019; cited 2020 25]. Available from: https://www.cdc.gov/pneumococcal/about/index.html
   Google Scholar
• Morimoto K, Suzuki M, Ishifuji T, et al. The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study. PLoS One. 2015;10(3):e0122247.
   PubMed Web of Science ®Google Scholar
• Health Service Bureau, Ministry of Health, Labour and Welfare. [Regarding the Enforcement, etc. of the Ministerial Order Partially Amending the Enforcement Regulation of the Act on the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (the Infectious Diseases Control Law) (Enforcement Notice)]. (No. 0307-(1) dated 7 March 2013). 2013. [cited 2020 Oct 15]. Available from: https://www.mhlw.go.jp/web/t_doc?dataId=00tb9101&dataType=1&pageNo=1
   Google Scholar
• National Institute of Infectious Diseases (NIID) Japan. Pneumococcal infections in 2017, Japan. IASR2018. p. 107–108.
   Google Scholar
• Health Service Bureau and Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare. [Regarding the Emergency Project for the Promotion of Vaccination Against Cervical Cancer, etc.] (No. 1126-(10) dated 26 November 2010). 2010. [cited 2020 Oct 15]. Available from: https://www.mhlw.go.jp/bunya/kenkou/other/dl/101209i.pdf
   Google Scholar
• Health Service Bureau, Ministry of Health, Labour and Welfare. [Regarding the Enforcement, etc. of the Act Partially Amending the Immunization Act] (No. 0330-(1) dated 30 March 2013)0. 2013. [cited 2020 Oct 15]. Available from: https://www.mhlw.go.jp/topics/bcg/tp250330-2.html
   Google Scholar
• Health Service Bureau, Ministry of Health, Labour and Welfare. [Regarding the enforcement, etc. of the ministerial order partially amending the enforcement regulation of the immunization act and the immunization practice regulation] (no. 0911-(1) dated 11 september 2013). 2013. [cited 2020 Oct 15]. Available from: https://www.mhlw.go.jp/web/t_doc?dataId=00tb9595&dataType=1&pageNo=1
   Google Scholar
• National Institute of Infectious Diseases (NIID) Japan. [Fact sheet on 13-valent pneumococcal conjugate vaccine (for Adults)] [updated 28 Jul 2015; cited 2015; cited 2020 Jul 2015; cited 2020 31 Jul 28 Jul 2015; cited 2020 31]. Available from: https://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000093331.pdf
   Google Scholar
• Health Service Bureau, Ministry of Health, Labour and Welfare. [Regarding the enforcement of the cabinet order partially amending the order for enforcement of the immunization act, and the ministerial order partially amending the enforcement regulation of the immunization act and the immunization practice regulation] (No. 0716-(24) dated 16 July 2014). 2014. [cited 2020 Oct 15]. Available from: https://www.mhlw.go.jp/web/t_doc?dataId=00tc0252&dataType=1&pageNo=1
   Google Scholar
• National Institute of Infectious Diseases (NIID) Japan. [Fact sheet on 10-valent pneumococcal conjugate vaccine] [updated 2016; cited 2020 Jan 2016; cited 2020 1 Jul 28 Jan 2016; cited 2020 1]. Available from: https://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/02shiryo1betten.pdf
   Google Scholar
• Pharmaceuticals and Medical Devices Agency (PMDA) Japan. [Information on updates of package insert within one month (9 December 2017)]. [cited 2020 Dec 17]. Available from: https://www.info.pmda.go.jp/psearch/tenpulist.jsp?DATE=20171209
   Google Scholar
• Glick HA, Miyazaki T, Hirano K, et al. One-year quality of life post-pneumonia diagnosis in Japanese adults. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020 May 24;ciaa595.
   Google Scholar
• National Institute of Informatics (NII) Japan. [Database of Grants-in-Aid Scientific Research (KAKEN)]. [cited 2020 Jun 2]. Available from: https://kaken.nii.ac.jp/
   Google Scholar
• National Institute of Infectious Diseases (NIID) Japan. National institute of infectious diseases. [cited 2020 Dec 11]. Available from: https://www.niid.go.jp/niid/en/
   Google Scholar
• Exchange rate for October 2021. Bank of Japan. 2021. [01 October 2021]. Available from: https://www.boj.or.jp/about/services/tame/tame_rate/kijun/kiju2110.htm
   Google Scholar
• National Institute of Infectious Diseases (NIID) Japan. Invasive Haemophilus influenzae and Streptococcus pneumoniae infections, as of August. 2014. IASR2014. p. 229–230.
   Google Scholar
• Suga S, Togashi T, Hosoya M, et al. [Current situation of invasive pneumococcal disease among children following the introduction of 13-valent pneumococcal conjugate vaccine]. IASR2018. p. 112–113.
   Google Scholar
• Suga S, Chang B, Asada K, et al. Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: effects of the seven-valent pneumococcal conjugate vaccine. Vaccine. 2015;33(45):6054–6060.
   PubMed Web of Science ®Google Scholar
• Kamidani S, Shoji K, Ogawa E, et al. High rate of febrile seizures in Japanese children with occult bacteremia. Pediatr Emerg Care. 2017;36(4):e199–e203.
   Google Scholar
• Naito S, Tanaka J, Nagashima K, et al. The impact of heptavalent pneumococcal conjugate vaccine on the incidence of childhood community-acquired pneumonia and bacteriologically confirmed pneumococcal pneumonia in Japan. Epidemiol Infect. 2016;144(3):494–506.
   PubMed Web of Science ®Google Scholar
• Ohtake S, Okada H, Hiramoto R. [The trend of invasive pneumococcal disease after introduction of pneumococcal conjugate vaccine]. Jpn J Pediatr. 2019. 06. 72(6):763–769.
   Google Scholar
• Konomura K, Nagai H, Akazawa M. Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective. Pneumonia. 2017;9(1):19.
   Google Scholar
• Chiba N, Morozumi M, Shouji M, et al. Rapid decrease of 7-valent conjugate vaccine coverage for invasive pneumococcal diseases in pediatric patients in Japan. Microb Drug Resist. 2013;19(4):308–315.
   PubMed Web of Science ®Google Scholar
• Oishi T, Wada A, Chang B, et al. Serotyping and multilocus sequence typing of Streptococcus pneumoniae isolates from the blood and posterior nares of Japanese children prior to the introduction of 7-valent pneumococcal conjugate vaccine. Jpn J Infect Dis. 2011;64(4):341–344.
   PubMed Web of Science ®Google Scholar
• Sakai F, Chiba N, Ono A, et al. Molecular epidemiologic characteristics of Streptococcus pneumoniae isolates from children with meningitis in Japan from 2007 through 2009 [原著論文]. [2007〜2009年の日本における髄膜炎小児からのStreptococcus pneumoniae分離株の分子疫学的特性]. J Infect Chemother. 2011 06; 17(3): 334–340.
   PubMed Web of Science ®Google Scholar
• Sakata H. Invasive Streptococcus pneumoniae infections in children in Kamikawa and Soya subprefecture, Hokkaido, Japan, 2000-2010, before the introduction of the 7-valent pneumococcal conjugate vaccine [原著論文]. [北海道の上川地方と宗谷地方の小児における7価肺炎球菌共役ワクチン導入前の2000〜2010年の侵襲的肺炎連鎖球菌感染症]. J Infect Chemother. 2011 12;17(6):799–802.
   PubMed Web of Science ®Google Scholar
• Nishimura T, Fukazawa M, Yoshida H, et al. [Clinical epidemiological study of occult pneumococcal bacteremia in a pediatric outpatient setting]. J Jpn Pediatr Soc. 2008 06;112(6):973–980.
   Google Scholar
• Hotomi M, Billal DS, Kamide Y, et al. Serotype distribution and penicillin resistance of Streptococcus pneumoniae isolates from middle ear fluids of pediatric patients with acute otitis media in Japan. J Clin Microbiol. 2008;46(11):3808–3810.
   PubMed Web of Science ®Google Scholar
• Kamiya H, Kato T, Togashi T, et al. [Epidemiological survey of pneumococcus serotypes in pediatric patients with acute suppurative otitis media] [原著論文]. J Jpn Assoc Infect Dis. 2007 01; 81(1): 59–66.
   PubMedGoogle Scholar
• Nakanishi N, Yonezawa T, Tanaka S, et al. Assessment of the local clonal spread of Streptococcus pneumoniae serotype 12F caused invasive pneumococcal diseases among children and adults. J Infect Public Health. 2019;12(6):867–872.
   PubMed Web of Science ®Google Scholar
• Kawahara R, Yamaguchi T, Katsukawa C, et al. [Serotype distribution of Streptococcus pneumoniae strains causing invasive pneumococcal disease in Osaka Prefecture, 2014-2017]. IASR2018. p. 110–111.
   Google Scholar
• Nakano S, Fujisawa T, Ito Y, et al. Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine, 2015-2017. Vaccine. 2020;38(7):1818–1824.
   PubMed Web of Science ®Google Scholar
• Mokuno E, Morozumi M, Ubukata K, et al. [Epidemiology of acute otitis media in children after introduction of the 13-valent pneumococcal conjugate vaccine] [原著論文]. Nippon Jibiinkoka Gakkai Kaiho. 2018 07; 121(7): 887–898.
   Google Scholar
• Miyazaki H, Shibuya R, Midorikawa N, et al. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated in Japan after introduction of the routine immunization program. J Infect Chemother. 2017;23(4):234–240.
   PubMed Web of Science ®Google Scholar
• Tanaka J, Ishiwada N, Wada A, et al. Incidence of childhood pneumonia and serotype and sequence-type distribution in Streptococcus pneumoniae isolates in Japan. Epidemiol Infect. 2012;140(6):1111–1121.
   PubMed Web of Science ®Google Scholar
• Miyahara H, Maruyama H, Kanazawa A, et al. Changes in the features of invasive pneumococcal disease after introduction of the seven-valent pneumococcal conjugate vaccine in a regional core hospital of Kochi, Japan. Acta Med Okayama. 2015;69(4):255–260.
   PubMed Web of Science ®Google Scholar
• Okade H, Funatsu T, Eto M, et al. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period. J Infect Chemother. 2014;20(7):423–428.
   PubMed Web of Science ®Google Scholar
• Chiba N, Kobayashi R, Hasegawa K, et al. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children. J Antimicrob Chemother. 2005;56(4):756–760.
   PubMed Web of Science ®Google Scholar
• Takemoto T, Matsubara K, Isome K, et al. [Invasive pneumococcal disease in children before and after the introduction of pneumococcal conjugate vaccine at a regional center in Kobe, Japan, 2002-2018] [原著論文]. J Jpn Assoc Infect Dis. 2019 07;93(4):485–492.
   Google Scholar
• Ubukata K, Takata M, Morozumi M, et al. Effects of pneumococcal conjugate vaccine on genotypic penicillin resistance and serotype changes, Japan, 2010-2017. Emerg Infect Dis. 2018;24(11):2010–2020.
   PubMed Web of Science ®Google Scholar
• Takeuchi N, Naito S, Ohkusu M, et al. Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan. Epidemiol Infect. 2020;148:e91.
   PubMed Web of Science ®Google Scholar
• Kadota T, Nomura N, Mitsuyama J, et al. [Sensitivity surveillance of Streptococcus pneumoniae isolates for several antibacterial agents in the Chubu region in Japan (2015-2016)] [原著論文]. Jpn J Antibiot. 2019 06;72(2):123–141.
   Google Scholar
• Nariai A. [Impact of the spread of pneumococcal conjugate vaccination on macrolide resistance in Streptococcus pneumoniae obtained from the nasopharynx of infants and young children] [原著論文]. Jpn J Antibiot. 2018. 03. 71(Suppl.A):61–66.
   Google Scholar
• Yanai T, Nariai A, Kanetaka T, et al. [Epidemiology of serotypes and drug-susceptibility of Streptococcus pneumoniae colonizing the nasopharynx in children (author’s transl)] [原著論文]. Kyosai Med J. 2018 05;67(2):201–205.
   Google Scholar
• Uozumi Y, Ozaki T, Nishimura N, et al. [Capsular serotypes of pediatric isolates of Streptococcus pneumoniae during one year from August 2016: comparison with those obtained in the two previous surveys] [原著論文]. Jpn J Med Technol. 2019 10;68(4):731–736.
   Google Scholar
• Chiba N, Morozumi M, Sunaoshi K, et al. Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan. Epidemiol Infect. 2010;138(1):61–68.
   PubMed Web of Science ®Google Scholar
• Shimbashi R, Fukusumi M, Shimada T, et al. [Clinical features of invasive pneumococcal disease among adults and analysis of serotype distribution of the causative bacteria]. Tokyo: IASR: NIID; 2018. p. 115–117.
   Google Scholar
• Akata K, Chang B, Yatera K, et al. The distribution and annual changes in the Streptococcus pneumoniae serotypes in adult Japanese patients with pneumococcal pneumonia from 2011 to 2015 [原著論文]. [2011〜2015年における日本人成人肺炎球菌性肺炎患者の肺炎連鎖球菌血清型の分布と経年変化]. J Infect Chemother. 2017 06; 23(5–6): 301–306.
   PubMed Web of Science ®Google Scholar
• Akuzawa N, Naito H. Nutritional parameters affecting severity of pneumonia and length of hospital stay in patients with pneumococcal pneumonia: a retrospective cross-sectional study. BMC Pulm Med. 2015;15(1):149.
   PubMedGoogle Scholar
• Akata K, Chang B, Yatera K, et al. Distribution and annual changes in Streptococcus pneumoniae serotypes in adult Japanese patients with pneumonia. J Infect Chemother. 2015;21(10):723–728.
   PubMed Web of Science ®Google Scholar
• Sando E, Suzuki M, Furumoto A, et al. Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: the japan pneumococcal vaccine effectiveness study (J-PAVE). Vaccine. 2019;37(20):2687–2693.
   PubMed Web of Science ®Google Scholar
• Shiragami M, Mizukami A, Leeuwenkamp O, et al. Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal vaccine in Japanese children. Infect Dis Ther. 2014;4(1):93–112.
   PubMed Web of Science ®Google Scholar
• Iwata S, Ishiwada N, Sakata H, et al. [Burden of illness of bacterial meningitis and bacteremia caused by Streptococcus pneumoniae in children] [原著論文]. Jpn J Pediatr. 2008 11;61(11):2206–2220.
   Google Scholar
• Suaya JA, Ohno T, Hilton B, et al. [Cost-effectiveness analysis of 13-valent versus 10-valent pneumococcal conjugate Vaccines as part of routine infant pneumococcal vaccination program in Japan] [原著論文]. Jpn J Pediatr. 2015 06;68(6):1197–1217.
   Google Scholar
• Uryu K, Nishiura S, Yamamoto T, et al. [Changes in medical treatment fees for pneumococcal pneumonia in our hospital before and after the introduction of DPC] [原著論文]. J Jpn Soc Clin Pathway. 2012 06;14(2):113–121.
   Google Scholar
• Satou M, Mutou M, Aoki H. [An disease burden and life convalescence of pneumococcal pneumonia of the elderly person - retrospective examination of a hospital the past three years] [原著論文]. Health Inf Manage. 2016. 03. 27(4):58–62.
   Google Scholar
• Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare. [Report on the deliberation results]. 2009. [updated 8 Sept; cited 2020 Sept; cited 2020 17 Nov 8 Sept; cited 2020 17]. Available from: https://www.pmda.go.jp/drugs/2009/P200900053/53039600_22100AMX02255_A100_1.pdf
   Google Scholar
• Pharmaceutical Safety Committee of the Pharmaceutical Affairs and Food Sanitation Council, Ministry of Health, Labour and Welfare. [Pediatric pneumococcal vaccination status and concurrent vaccination (provided by Pfizer Inc.)]. 2011. [cited 2020 Nov 17]. Available from: https://www.mhlw.go.jp/stf/shingi/2r9852000001dn2t-att/2r9852000001dn5f.pdf
   Google Scholar
• Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare. [Report on the deliberation results]. 2015. [updated 2020 Mar; cited 2020 17 Nov 10 Mar; cited 2020 17]. Available from: https://www.pmda.go.jp/drugs/2015/P201500029/342275000_22700AMX00660_A100_1.pdf
   Google Scholar
• Pharmaceuticals and Medical Devices Agency (PMDA) Japan. [Drug interview form “prevenar 13® suspension liquid for injection”]. 2020. [updated Oct; cited 2020 Oct; cited 2020 17 Nov 17]. Available from: https://www.info.pmda.go.jp/go/interview/2/672212_631140EC1022_2_1F.pdf
   Google Scholar
• Pharmaceuticals and Medical Devices Agency (PMDA) Japan. [Drug Interview Form “PNEUMOVAX® NP”]. 2020. [updated Oct; cited 2020 Oct; cited 2020 17 Nov 17]. Available from: https://www.info.pmda.go.jp/go/interview/2/170050_6311400A1037_2_016_1F.pdf
   Google Scholar
• Number of people administered routine vaccinations. 1995-2019.: Ministry of health, labour and welfare. [2021 Jun 26]. Available from: https://www.mhlw.go.jp/topics/bcg/other/5.html
   Google Scholar
• Nakamura A, Kawakami K, Wakana A, et al. A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) revaccination coverage rate among elderly adults aged 65 and older and physician’s attitude. Hum Vaccin Immunother. 2020 Sep 1;16(9):2292–2299.
   PubMed Web of Science ®Google Scholar
• Reported number of invasive pneumococcal infections based on the Infectious Diseases Control Law. 2013-2017. National Institute of Infectious Diseases. [cited 2021 Jun 26]. Available from: https://www.niid.go.jp/niid/ja/pneumococcal-m/pneumococcal-idwrs/8041-ipd-180517.html
   Google Scholar
• Blommaert A, Bilcke J, Willem L, et al. The cost-effectiveness of pneumococcal vaccination in healthy adults over 50: an exploration of influential factors for Belgium. Vaccine. 2016 April 19;34(18):2106–2112.
   PubMed Web of Science ®Google Scholar
• Shinjoh M, Yamaguchi Y, Iwata S. Pediatric bacterial meningitis in Japan, 2013-2015-3-5 years after the wide use of Haemophilus influenzae type b and Streptococcus pneumoniae conjugated vaccines. J Infect Chemother. 2017;23(7):427–438.
   PubMed Web of Science ®Google Scholar
• Fukazawa M. [Efficacy of Hib and 7-valent pneumococcal vaccine from bacteremia cases for 11 years in practicing pediatrics (author’s transl)] [原著論文]. Fukuoka-Ken-Ihou. 2017;04(1490):57–59.
   Google Scholar
• Tamura YB, Matsubara K, Matsubara C, et al. [Trend of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Hiroshima city] [原著論文]. J Pediatric Infect Dis Immunol. 2017 10;29(3):241–248.
   Google Scholar
• Sakata H. Invasive pneumococcal diseases in children in Hokkaido, Japan from April 2000, to March 2015. J Infect Chemother. 2016;22(1):24–26.
   PubMed Web of Science ®Google Scholar
• Ishiwada N, Hishiki H, Nagasawa K, et al. The incidence of pediatric invasive Haemophilus influenzae and pneumococcal disease in Chiba prefecture, Japan before and after the introduction of conjugate vaccines. Vaccine. 2014;32(42):5425–5431.
   PubMed Web of Science ®Google Scholar
• Nakamura R, Togashi T. Population-based incidence of invasive haemophilus influenzae and pneumococcal diseases before the introduction of vaccines in Japan. Pediatr Infect Dis J. 2013;32(12):1394–1396.
   PubMed Web of Science ®Google Scholar
• Togashi T, Sakata H, Tsutsumi H, et al. [Epidemiology of bacteria meningitis in childhood just before the introduction of conjugate vaccines in Hokkaido, the Northernmost Island of Japan] [原著論文]. J Jpn Pediatr Soc. 2010 03;114(3):473–478.
   Google Scholar
• Higashigawa M, Suzuki M, Omori Y, et al. [Clinical investigation of 26 cases of bacteremia in infants and children] [原著論文]. J Jpn Pediatr Soc. 2009 10;113(10):1557–1563.
   Google Scholar
• Ishiwada N, Kurosaki T, Terashima I, et al. The incidence of pediatric invasive pneumococcal disease in Chiba prefecture, Japan (2003-2005). J Infect. 2008;57(6):455–458.
   PubMed Web of Science ®Google Scholar
• Ogita J, Ishiwada N, Kurosaki T, et al. [Incidence of community-acquired pneumonia and pneumococcal pneumonia, among children in Chiba City, Japan]. J Jpn Assoc Infect Dis. 2008;82(6):624–627.
   PubMedGoogle Scholar
• Sakata H. [Study of Streptococcus pneumoniae bacteremia in children] [原著論文]. J Jpn Assoc Infect Dis. 2005 01;79(1):1–6.
   PubMedGoogle Scholar
• Takaki M, Nakama T, Ishida M, et al. High incidence of community-acquired pneumonia among rapidly aging population in Japan: a prospective hospital-based surveillance. Jpn J Infect Dis. 2014;67(4):269–275.
   PubMed Web of Science ®Google Scholar
• Kubota T, Ishida M, Tokaji A, et al. [Current status of invasive pneumococcal disease in Kochi] [原著論文]. J Kochi Med Assoc. 2019 03;24(1):171–178.
   Google Scholar
• Griffith MM, Fukusumi M, Kobayashi Y, et al. Epidemiology of vaccine-preventable diseases in Japan: considerations for pre-travel advice for the 2019 Rugby World Cup and 2020 Summer Olympic and Paralympic Games. Western Pac Surveill Response J. 2018;9(2):26–33.
   PubMedGoogle Scholar
• Obara H, Saitou J, Fukuda H. [Increased burden on medical resources of penicillin-resistant Streptococcus pneumoniae infections: estimmates using JANIS data] [原著論文]. Jpn J Environ Infect. 2015 05;30(3):165–173.
   Google Scholar
• Hishiki H, Ishiwada N, Fukasawa C, et al. Incidence of bacterial coinfection with respiratory syncytial virus bronchopulmonary infection in pediatric inpatients. J Infect Chemother. 2011;17(1):87–90.
   PubMed Web of Science ®Google Scholar
• Ishiwada N, Niwa K, Tateno S, et al. Pneumococcal endocarditis in children: a nationwide survey in Japan. Int J Cardiol. 2008;123(3):298–301.
   PubMed Web of Science ®Google Scholar
• Ariga S, Imataka G, Yoshida A, et al. Bacteriological study of 53 children with bacterial meningitis in our hospital (2000-2017) [原著論文]. [当院(2000〜2017年)における細菌性髄膜炎の患児53名の細菌学的研究]. Dokkyo J Med Sci. 2017 07;44(2):169–171.
   Google Scholar
• Haro K, Ogawa M, Hoshina T, et al. Difference between Japanese secondary and tertiary medical facilities regarding changes in the hospitalization of children for pneumonia after the introduction of the pneumococcal conjugate vaccine. Jpn J Infect Dis. 2017;70(3):270–274.
   PubMed Web of Science ®Google Scholar
• Hoshino T, Takeuchi N, Fukasawa C, et al. Analysis of Streptococcus pneumoniae and Haemophilus influenzae isolated from middle ear fluid before and after the introduction of government subsidies for pneumococcal and H. influenzae type b vaccines in Japan. J Infect Chemother. 2017;23(2):85–89.
   PubMed Web of Science ®Google Scholar
• Nariai A, Uchimura T, Kanetaka T, et al. [Effects of widely used of 7-valent pneumococcal conjugate vaccine on serotypes of colonized Streptococcus pneumoniae infants and young children with lower respiratory tract infections] [原著論文]. J Pediatric Infect Dis Immunol. 2014 07;26(2):213–219.
   Google Scholar
• Otsuka T, Kitami O, Kondo K, et al. Incidence survey of acute otitis media in children in Sado Island, Japan–Sado Otitis Media Study (SADOMS). PLoS One. 2013;8(7):e68711.
   PubMed Web of Science ®Google Scholar
• Takano M, Ozaki K, Nitahara Y, et al. Streptococcus pneumoniae and Haemophilus influenzae at the initial stage of influenza. Pediatr Int. 2009;51(5):687–695.
   PubMed Web of Science ®Google Scholar
• Ishida T, Tachibana H, Ito A, et al. Clinical characteristics of severe community-acquired pneumonia among younger patients: an analysis of 18 years at a community hospital. J Infect Chemother. 2014;20(8):471–476.
   PubMed Web of Science ®Google Scholar
• Kimura M, Kataoka K, Kato K, et al. [Clinical study of adult community-acquired pneumonia with respiratory failure in our hospital (author’s transl)] [原著論文]. Med J Tosei General Hospital. 2008;10(24):1–6.
   Google Scholar
• Oda K, Yatera K, Fujino Y, et al. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Respir Investig. 2018;56(1):64–71.
   PubMed Web of Science ®Google Scholar
• Kurai D, Sasaki Y, Saraya T, et al. Pathogen profiles and molecular epidemiology of respiratory viruses in Japanese inpatients with community-acquired pneumonia. Respir Investig. 2016;54(4):255–263.
   PubMed Web of Science ®Google Scholar
• Yoshii Y, Shimizu K, Morozumi M, et al. Identification of pathogens by comprehensive real-time PCR versus conventional methods in community-acquired pneumonia in Japanese adults. Infect Dis (Auckl). 2016 [2016 December 01];48(11–12):782–788.
   PubMed Web of Science ®Google Scholar
• Ryu K, Takayanagi N, Ishiguro T, et al. Etiology and outcome of diffuse acute infectious bronchiolitis in adults. Ann Am Thorac Soc. 2015;12(12):1781–1787.
   PubMed Web of Science ®Google Scholar
• Fukuyama H, Yamashiro S, Tamaki H, et al. A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP). J Infect Chemother. 2013;19(4):719–726.
   PubMed Web of Science ®Google Scholar
• Abe T, Tokuda Y, Ishimatsu S, et al. Usefulness of initial blood cultures in patients admitted with pneumonia from an emergency department in Japan. J Infect Chemother. 2009;15(3):180–186.
   PubMed Web of Science ®Google Scholar
• Kobashi Y, Yoshida K, Miyashita N, et al. Evaluating the use of a Streptococcus pneumoniae urinary antigen detection kit for the management of community-acquired pneumonia in Japan. Respiration. 2007;74(4):387–393.
   PubMed Web of Science ®Google Scholar
• Miyashita N, Fukano H, Mouri K, et al. Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study. J Med Microbiol. 2005;54(Pt 4):395–400.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Dhoubhadel BG, Ishifuji T, et al. Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. Lancet Infect Dis. 2017;17(3):313–321.
   PubMed Web of Science ®Google Scholar
• Kumagai S, Ishida T, Tachibana H, et al. Polybacterial aetiology and outcomes in patients with community-acquired pneumonia. Int J Tuberc Lung Dis. 2016;20(1):129–135.
   PubMed Web of Science ®Google Scholar
• Ichikawa T, Otsuka S, Iwasaki M, et al. [Study of pneumonia admissions in the Department of Respiratory Medicine at our hospital in 2016 (author’s transl)] [原著論文]. J Asahikawa City Hospital. 2019 12;51(1):1–6.
   Google Scholar
• Nariai A, Yanai T, Kanetaka T. [Epidemiology of pneumococci obtained from the nasopharynx of infants and young children before and after transition to 13-valent pneumococcal conjugate vaccine: change of serotypes] [原著論文]. J Jpn Pediatr Soc. 2016. 04. 120(4):744–751.
   Google Scholar
• Ozawa D, Yano H, Endo S, et al. Impact of the seven-valent pneumococcal conjugate vaccine on acute otitis media in Japanese children: emergence of serotype 15A multidrug-resistant Streptococcus pneumoniae in middle ear fluid isolates. Pediatr Infect Dis J. 2015;34(9):e217–21.
   PubMed Web of Science ®Google Scholar
• Chiba N, Morozumi M, Shouji M, et al. Changes in capsule and drug resistance of Pneumococci after introduction of PCV7, Japan, 2010-2013. Emerg Infect Dis. 2014;20(7):1132–1139.
   PubMed Web of Science ®Google Scholar
• Abe T, Furuno K, Bin C, et al. [Bacteriological analysis of pneumococcus detected from the sputum of hospitalized children] [原著論文]. J Jpn Assoc Infect Dis. 2017 03;91(2):137–144.
   PubMedGoogle Scholar
• Kawaguchiya M, Urushibara N, Aung MS, et al. Serotype distribution, antimicrobial resistance and prevalence of pilus islets in pneumococci following the use of conjugate vaccines. J Med Microbiol. 2017;66(5):643–650.
   PubMed Web of Science ®Google Scholar
• Kawaguchiya M, Urushibara N, Aung MS, et al. Emerging non-PCV13 serotypes of noninvasive Streptococcus pneumoniae with macrolide resistance genes in northern Japan. New Microbes New Infect. 2016;9:66–72.
   PubMedGoogle Scholar
• Nakano S, Fujisawa T, Ito Y, et al. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014. Vaccine. 2016;34(1):67–76.
   PubMed Web of Science ®Google Scholar
• Uda K, Morikawa Y, Ito K, et al. [Serotype replacement of invasive pneumococcal disease after introduction of pneumococcal conjugated vaccine at children’s hospital in Japan] [原著論文]. J Pediatric Infect Dis Immunol. 2015 04;27(1):9–15.
   Google Scholar
• Kawaguchiya M, Urushibara N, Ghosh S, et al. Serotype distribution and susceptibility to penicillin and erythromycin among noninvasive or colonization isolates of Streptococcus pneumoniae in northern Japan: a cross-sectional study in the pre-PCV7 routine immunization period. Microb Drug Resist. 2014;20(5):456–465.
   PubMed Web of Science ®Google Scholar
• Eto M, Mizunaga S, Fukuda Y, et al. [Sensitivity surveillance of Streptococcus pneumoniae isolates for several antibacterial agents in Gifu and Aichi prefecture (2010-2011)] [原著論文]. Jpn J Antibiot. 2013 10;66(5):265–282.
   PubMedGoogle Scholar
• Nariai A, Uchimura T, Kanetaka T, et al. [Epidemiology of pneumococcal strains obtained from the nasopharynx of infants and young children with lower respiratory tract infection before the distribution of 7-valent conjugate vaccine in 2010] [原著論文]. J Jpn Pediatr Soc. 2013 11;117(11):1759–1766.
   Google Scholar
• Fukusumi M, Chang B, Tanabe Y, et al. Invasive pneumococcal disease among adults in Japan, April 2013 to March 2015: disease characteristics and serotype distribution. BMC Infect Dis. 2017;17(1):2.
   PubMedGoogle Scholar
• Maeda Y, Akiba Y, Kajiwara Y, et al. [Study of adult invasive pneumococcal disease (IPD) in our hospital (author’s transl)] [原著論文]. J Chiba Assoc Med Technol. 2019;10(137):6–10.
   Google Scholar
• Furuya Y, Yamagishi Y, Okade H, et al. Impact of the pneumococcal conjugate vaccine on serotype distribution of adult non-invasive Streptococcus pneumoniae isolates in Tokai region, Japan, 2008-2016. J Infect Chemother. 2017;23(6):394–399.
   PubMed Web of Science ®Google Scholar
• Shoji H, Maeda M, Takuma T, et al. Serotype distribution of Streptococcus pneumoniae isolated from adult respiratory tract infections in nationwide Japanese surveillances from 2006 to 2014. J Infect Chemother. 2017;23(8):538–544.
   PubMed Web of Science ®Google Scholar
• Hosoya M, Inomata A, Kimura Y, et al. [Serotype distribution of Streptococcus pneumoniae isolates from invasive pneumococcal disease patients in Niigata prefecture] [原著論文]. Annual Report of Niigata Prefectural Institute of Public Health and Environmental Sciences. 2015 .10;30:62–66.
   Google Scholar
• Shoji H, Maeda M, Shirakura T, et al. Changes in the distribution of capsular serotypes of streptococcus pneumoniae isolated from adult respiratory specimens in Japan [原著論文]. [日本における成人呼吸器検体から分離された肺炎球菌の莢膜血清型の分布における変化]. Intern Med. 2015 06; 54(11): 1337–1341.
   PubMed Web of Science ®Google Scholar
• Ubukata K, Chiba N, Hanada S, et al. Serotype changes and drug resistance in invasive pneumococcal diseases in adults after vaccinations in children, Japan, 2010-2013. Emerg Infect Dis. 2015;21(11):1956–1965.
   PubMed Web of Science ®Google Scholar
• Noguchi S, Yatera K, Akata K, et al. Distribution and annual changes in the proportion of Streptococcus pneumoniae serotypes in Japanese adults with pneumococcal pneumonia from 2011 to 2017. J Infect Chemother. 2019;25(11):925–929.
   PubMed Web of Science ®Google Scholar
• Toda H, Tanaka Y, Satoh K, et al. Epidemiological and molecular characterization of invasive Streptococcus pneumoniae isolated following introduction of 7-valent conjugate vaccine in Kinki region, Japan, 2008-2013. J Infect Chemother. 2020;26(5):451–458.
   PubMed Web of Science ®Google Scholar
• Nakano S, Matsumura Y, Ito Y, et al. Development and evaluation of MALDI-TOF MS-based serotyping for Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis. 2015;34(11):2191–2198.
   PubMed Web of Science ®Google Scholar
• Hotomi M, Togawa A, Kono M, et al. PspA family distribution, antimicrobial resistance and serotype of Streptococcus pneumoniae isolated from upper respiratory tract infections in Japan. PLoS One. 2013;8(3):e58124.
   PubMed Web of Science ®Google Scholar
• Hotomi M, Nakajima K, Hiraoka M, et al. Molecular epidemiology of nonencapsulated Streptococcus pneumoniae among Japanese children with acute otitis media. J Infect Chemother. 2016;22(2):72–77.
   PubMed Web of Science ®Google Scholar
• Yamagishi Y, Mikamo H, Sawamura H, et al. [Epidemiological analysis of Streptococcus pneumoniae in Gifu prefecture and the northern district of Aichi prefecture −2009-] [原著論文]. Jpn J Antibiot. 2012 02;65(1):27–47.
   PubMedGoogle Scholar
• Suzuki H, Tokuda Y, Shichi D, et al. Morbidity and mortality among newly hospitalized patients with community-acquired pneumococcal bacteremia: a retrospective cohort study in three teaching hospitals in Japan [原著論文]. [市中肺炎球菌性菌血症の新規入院患者における合併症および死亡率 日本の教育病院3施設における後向きコホート研究]. Geriat Gerontol Int. 2013 07; 13(3): 607–615.
   PubMed Web of Science ®Google Scholar
• Ishiwada N, Iwata S, Sakata H, et al. [Burden of illness of pneumonia caused by Streptococcus pneumoniae in chilren] [原著論文]. Jpn J Pediatr. 2008 11;61(11):2194–2204.
   Google Scholar
• Uda A, Tokimatsu I, Koike C, et al. Antibiotic de-escalation therapy in patients with community-acquired nonbacteremic pneumococcal pneumonia. Int J Clin Pharm. 2019;41(6):1611–1617.
   PubMed Web of Science ®Google Scholar
• Shinjoh M, Iwata S, Yagihashi T, et al. Recent trends in pediatric bacterial meningitis in Japan–a country where Haemophilus influenzae type b and Streptococcus pneumoniae conjugated vaccines have just been introduced. J Infect Chemother. 2014 Aug;20(8):477–483.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Matsui T, Tachibana T, et al. Factors associated with acute otitis media in children due to penicillin intermediately resistant Streptococcus pneumoniae. Int J Pediatr Otorhinolaryngol. 2009;73(10):1344–1347.
   PubMed Web of Science ®Google Scholar